Spartan Therapeutics pioneers mRNA-based tissue reprogramming to restore youthful function in organs and combat age-related decline.
Spartan Therapeutics is dedicated to preventing the onset of old age and its associated diseases. We develop mRNA-based therapeutics that reprogram tissues systemically, restoring youthful transcriptome profiles, biomarkers, and function across major organs — without the risks and complexity of full cellular reprogramming (e.g., Yamanaka factors).
Longevity researcher, biotech engineer, PhD candidate in tissue reprogramming, and author of The Anti-Aging Toolkit. Educated through Harvard Medical School programs in gene editing, nucleic acid therapeutics, cell biology, and more. Holds a postgraduate degree in Astronomy from Swinburne University.
Raymond's work focuses on delivering nucleic acids to restore youthful microenvironments in tissues like heart, liver, brain, skin, bone, and kidneys — aiming for clinical translatability, affordability, and broad healthspan extension.
Linked with Teloskin (longevity skincare funding tissue research), academic networks, and the global longevity biotech community.